Latest News
Asia
AKSO partners with Huadong Pharmaceutical to bring 'exciting cancer immunotherapy' to Asia
By Kaleb Brown | Feb 27, 2022
AKSO Biopharmaceutical Inc., a global pharmaceutical company with an innovative approach to cancer treatment, is partnering with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, to develop and sell AB002 in the Pacific Asia region.